Invented by Sander Woutersen and Giulia Giubertoni, InSpectT’s patented technology enables the measurement of molecular size and chemical structure in one workflow. This makes it possible to characterise mixtures of molecules or particles that contain a broad range of sizes and structures. Such mixtures occur nearly everywhere in the modern chemistry lab, ranging from functional nanoparticles to smart coatings and life-saving mRNA vaccines. Currently, R&D teams in these research fields typically use several methods at the same time to characterise complex mixtures, whereas with InSpectT’s technology one single measurement can be sufficient.

Over the past four years, the company has secured a series of competitive grants to turn its academic research into a viable commercial product. "The Take-Off II loan will help InSpectT to grow from a laboratory idea into a real, scalable business,” says Giubertoni, InspectT’s CEO.

A big "Thank You"

Giubertoni, Woutersen and their team are very grateful to their early adopters (academic and industrial), and to their host institute, the Van 't Hoff Institute for Molecular Sciences at the University of Amsterdam. “We want to thank all our early adopters, and our colleagues at HIMS,” says Giubertoni. “Their encouragement and suggestions, both scientific and non-scientific, have been so important for us! So we just want to say a big “Thank You” to all of them.”

About the Take-off phase 2 loan

The Take-off funding scheme of the Dutch Research Council NWO aims to create innovative activities based on knowledge development and utilisation by researchers at knowledge institutions. This can be about product, process, care or service innovation in the broadest sense of the word and within all scientific areas. In phase 2 of the scheme ("Vroegefasetrajecten"), companies (start-ups) initiated by researchers or entrepreneurs can request a loan of €50,000 to a maximum of €450,000 to support achieving commercial viability.

See also

• InspectT
• Two Faculty of Impact fellowships for HIMS researchers
• Giulia Giubertoni and Sander Woutersen receive IXA Proof-of-Concept funding
• InspectT ontvangt financiering van het Innovatiefonds Noord-Holland